Company introduction

Company introduction
Samyang
Biopharmaceuticals Sewon Cellontech
Corporation. Co., Ltd.

Samyang Biopharmaceuticals Corporation, Sewon Cellontech Co., Ltd., established in 1971,

with its central research center is engaged in offers full-array of products through its three
the development and marketing of novel drug business divisions: Plant Equipment, Mechatronics
delivery systems and medical devices. System and RMS (Regenerative Medical System).
Samyang Biopharmaceuticals Corporation is focusing its efforts on Since 1996, RMS has conducted comprehensive researches to identify
healthcare as its core strategic business of the 21st century. Samyang the major key factors in the tissue regeneration. With the cutting-edge
Biopharmaceuticals Corporation is developing proprietary and unique technologies, RMS has developed innovative products in the field of
core technologies for the development of world class novel drug regenerative medicine and created two portfolios of products termed as
delivery systems. RegenGraft (BioCollagen Scaffold) and Stem Cell System(Cell therapy).
RMS’s mission is to design, develop and manufacture biocompatible
R&D Pipeline therapeutic materials according to specific design criteria to meet diverse
clinical needs. RMS has been dedicating in research to create a new CEO
Technology concept for regenerative medicine industry and to deliver the optimized Cheong-Ho Chang M.D.
Category Products Development Status
Description solution to clinicians throughout the world. Currently, RMS products are Location
in the world-wide market, especially in EU, North America and Japan. 8th FL. Wooyoung
Plant Cell Culture Paclitaxel Marketed Techno Center, 144 Achasan-ro,
Seongdong-Gu, Seoul 133-831,
Epothilones Pilot production Korea
Fermentation Homepage
Sirolimus Under development
contact@swcell.com
Fermentation / EC Representative
Liraglutide Under development
API Organic Synthesis RMS INNOVATIONS (U.K)
LIMITED
CEO
Taeung Eom Location
Paclitaxel Marketed 310 Centennial Park, Elstree,
Location Docetaxel Marketed Hertfordshire
31, Jong-ro 33-gil, Jongno-gu, Organic Synthesis Pemetrexed Marketed WD6 3TJ United Kingdom
Seoul, 110-725, Korea Bortezomib Pilot production Homepage
Homepage Cabazitaxel Under development sales@RMSbio.net
www.samyangbiopharm.com

54 55